Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anika Therapeutics

11.27
-0.5100-4.33%
Post-market: 11.270.00000.00%16:04 EDT
Volume:76.05K
Turnover:857.17K
Market Cap:161.63M
PE:-2.90
High:11.65
Open:11.65
Low:11.10
Close:11.78
Loading ...
Apr 28, 2023

Major Issues Report

8-K - Current report
Apr 13, 2023

Major Issues Report

8-K - Current report
Apr 05, 2023

Correspondence

Form CORRESP - Correspondence
Mar 16, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 01, 2022

Major Issues Report

8-K - Current report
Oct 07, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 05, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2022

Major Issues Report

8-K - Current report
Jun 10, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 06, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2022

Major Issues Report

8-K - Current report